Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alendronic acid 70mg tablets
0606020A0AAACAC
|
Alendronic acid | Alendronic acid | Endocrine System | 1,329,415 |
|
Alendronic acid 70mg effervescent tablets sugar free
0606020A0AAAHAH
|
Alendronic acid | Alendronic acid | Endocrine System | 24,450 |
|
Alendronic acid 10mg tablets
0606020A0AAAAAA
|
Alendronic acid | Alendronic acid | Endocrine System | 2,892 |
|
Alendronic acid 70mg/100ml soln unit dose sugar free
0606020A0AAAFAF
|
Alendronic acid | Alendronic acid | Endocrine System | 2,207 |
|
Alendronic acid 35mg/5ml oral solution
0606020A0AAADAD
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Alendronic acid 5mg tablets
0606020A0AAABAB
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Alendronic acid 70mg/5ml oral solution
0606020A0AAAEAE
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
|
Alendronic acid 70mg/75ml oral solution unit dose
0606020A0AAAGAG
|
Alendronic acid | Alendronic acid | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.